No abstract

Administration of autologous invariant natural killer T (iNKT) cells was safe and well-tolerated in patients with HCC (BCLC B/C).• Expanded iNKT cells produced Th1-like responses with possible antitumor activity.• No severe adverse events were observed in any of the enrolled patients, including one patient who received 10 10 in vitro-expanded autologous iNKT cells as a single infusion.

Different MDR characteristics were exhibited in well and poorly differentiated gastric carcinomas, which may be caused by different expressed MDR associated factors in these tissues.

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.